| Barry J Knapp, MD | |
|
4092 Foxwood Dr, Virginia Beach, VA 23462-5225 | |
| (757) 467-4200 | |
| Not Available |
| Full Name | Barry J Knapp |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 30 Years |
| Location | 4092 Foxwood Dr, Virginia Beach, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073545612 | NPI | - | NPPES |
| 5810183 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 0101055984 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sentara Norfolk General Hospital | Norfolk, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emergency Physicians Of Tidewater | 5092618462 | 150 |
News Archive
LENSAR Inc., developer of the next generation LENSAR Laser System™ for refractive cataract surgery, announced today that the company's laser system has received 510(k) clearance from the United States Food and Drug Administration (FDA) for executing corneal incisions during cataract surgery.
Surgeons are treating patients with a new type of hip implant that could lead to better outcomes for younger, more active people requiring surgery.
In a letter to leaders of the U.S. House of Representatives Ways and Means, and Energy and Commerce committees, the president of the American College of Physicians (ACP) expressed support for the Children's Health and Medicare Preotection (CHAMP) Act of 2007 (H.R. 3162).
The final step in the multidisciplinary approach of gender reassignment therapy in female-to-male transsexuals consists of the construction of a neophallus to allow the patient to void while standing and to have sexual experience after he is accustomed to his new voiding abilities. The main limiting factor is that there is no good substitute for the unique erectile tissue of the penis. The largest retrospective study by Hoebeke et al. evaluates the outcome in 129 female-to-male transsexuals after implantation of a hydraulic erectile prosthesis.
Omni Bio Pharmaceutical, Inc., an emerging biopharmaceutical company formed to acquire, license, and develop existing therapies for indications with substantial commercialization potential, has committed to expand its Phase I/II human clinical trial in recently diagnosed Type 1 diabetes patients from 15 patients to 50.
› Verified 4 days ago
| Entity Name | Emergency Physicians Of Tidewater |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033136841 PECOS PAC ID: 5092618462 Enrollment ID: O20040202000195 |
News Archive
LENSAR Inc., developer of the next generation LENSAR Laser System™ for refractive cataract surgery, announced today that the company's laser system has received 510(k) clearance from the United States Food and Drug Administration (FDA) for executing corneal incisions during cataract surgery.
Surgeons are treating patients with a new type of hip implant that could lead to better outcomes for younger, more active people requiring surgery.
In a letter to leaders of the U.S. House of Representatives Ways and Means, and Energy and Commerce committees, the president of the American College of Physicians (ACP) expressed support for the Children's Health and Medicare Preotection (CHAMP) Act of 2007 (H.R. 3162).
The final step in the multidisciplinary approach of gender reassignment therapy in female-to-male transsexuals consists of the construction of a neophallus to allow the patient to void while standing and to have sexual experience after he is accustomed to his new voiding abilities. The main limiting factor is that there is no good substitute for the unique erectile tissue of the penis. The largest retrospective study by Hoebeke et al. evaluates the outcome in 129 female-to-male transsexuals after implantation of a hydraulic erectile prosthesis.
Omni Bio Pharmaceutical, Inc., an emerging biopharmaceutical company formed to acquire, license, and develop existing therapies for indications with substantial commercialization potential, has committed to expand its Phase I/II human clinical trial in recently diagnosed Type 1 diabetes patients from 15 patients to 50.
› Verified 4 days ago
| Entity Name | Observation Physicians Of Tidewater |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306590450 PECOS PAC ID: 8123401429 Enrollment ID: O20220819000428 |
News Archive
LENSAR Inc., developer of the next generation LENSAR Laser System™ for refractive cataract surgery, announced today that the company's laser system has received 510(k) clearance from the United States Food and Drug Administration (FDA) for executing corneal incisions during cataract surgery.
Surgeons are treating patients with a new type of hip implant that could lead to better outcomes for younger, more active people requiring surgery.
In a letter to leaders of the U.S. House of Representatives Ways and Means, and Energy and Commerce committees, the president of the American College of Physicians (ACP) expressed support for the Children's Health and Medicare Preotection (CHAMP) Act of 2007 (H.R. 3162).
The final step in the multidisciplinary approach of gender reassignment therapy in female-to-male transsexuals consists of the construction of a neophallus to allow the patient to void while standing and to have sexual experience after he is accustomed to his new voiding abilities. The main limiting factor is that there is no good substitute for the unique erectile tissue of the penis. The largest retrospective study by Hoebeke et al. evaluates the outcome in 129 female-to-male transsexuals after implantation of a hydraulic erectile prosthesis.
Omni Bio Pharmaceutical, Inc., an emerging biopharmaceutical company formed to acquire, license, and develop existing therapies for indications with substantial commercialization potential, has committed to expand its Phase I/II human clinical trial in recently diagnosed Type 1 diabetes patients from 15 patients to 50.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Barry J Knapp, MD Po Box 7549, Portsmouth, VA 23707-0549 Ph: (757) 686-3508 | Barry J Knapp, MD 4092 Foxwood Dr, Virginia Beach, VA 23462-5225 Ph: (757) 467-4200 |
News Archive
LENSAR Inc., developer of the next generation LENSAR Laser System™ for refractive cataract surgery, announced today that the company's laser system has received 510(k) clearance from the United States Food and Drug Administration (FDA) for executing corneal incisions during cataract surgery.
Surgeons are treating patients with a new type of hip implant that could lead to better outcomes for younger, more active people requiring surgery.
In a letter to leaders of the U.S. House of Representatives Ways and Means, and Energy and Commerce committees, the president of the American College of Physicians (ACP) expressed support for the Children's Health and Medicare Preotection (CHAMP) Act of 2007 (H.R. 3162).
The final step in the multidisciplinary approach of gender reassignment therapy in female-to-male transsexuals consists of the construction of a neophallus to allow the patient to void while standing and to have sexual experience after he is accustomed to his new voiding abilities. The main limiting factor is that there is no good substitute for the unique erectile tissue of the penis. The largest retrospective study by Hoebeke et al. evaluates the outcome in 129 female-to-male transsexuals after implantation of a hydraulic erectile prosthesis.
Omni Bio Pharmaceutical, Inc., an emerging biopharmaceutical company formed to acquire, license, and develop existing therapies for indications with substantial commercialization potential, has committed to expand its Phase I/II human clinical trial in recently diagnosed Type 1 diabetes patients from 15 patients to 50.
› Verified 4 days ago
Ioliene Boenau, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3914 W Stratford Rd, Virginia Beach, VA 23455 Phone: 757-460-5924 | |
Moss H Mendelson, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 4092 Foxwood Dr, Suite 101, Virginia Beach, VA 23462 Phone: 757-467-4200 | |
Anthony C Cetrone, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 6632 Indian River Rd, Virginia Beach, VA 23464 Phone: 757-424-4300 Fax: 757-523-0632 | |
Dr. Natalie Sobota Feldman, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4092 Foxwood Dr, Ste 101, Virginia Beach, VA 23462 Phone: 757-686-3508 Fax: 757-686-0541 | |
Christopher L Gibert, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4092 Foxwood Dr, Suite 101, Virginia Beach, VA 23462 Phone: 757-467-4200 | |
Dr. Andy Cameron Bunch, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4092 Foxwood Dr Ste 101, Virginia Beach, VA 23462 Phone: 757-467-4200 | |
Beverly Nyokabi, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4445 Corporation Ln Ste 264, Virginia Beach, VA 23462 Phone: 540-776-4028 |